Key Takeaways “Clinically proven” is a marketing phrase with no single legal definition, but the FTC’s substantiation doctrine requires claims to be backed by evidence that matches the claim’s scope. Substantiation tiers range from anecdotal testimonials (weakest) through in vitro data, animal-model studies, and randomized controlled trials (strongest). The National Advertising Division (NAD) handles most…
Key Takeaways Private-equity acquisitions of pet supplement brands have accelerated sharply since 2020, with deal values routinely exceeding half a billion dollars for category leaders. PE-owned brands often show the same post-acquisition pattern: formulation simplification, label redesigns, and reduced third-party testing — changes that can compromise product quality without triggering a single recall. Litigation and…
Key Takeaways The pet supplement industry relies heavily on a small number of contract manufacturers and co-packers, meaning many “brands” share production lines, formulations, or even finished products. White-label and private-label business models dominate chews and soft chews, and most consumer-facing brands disclose almost nothing about who actually makes their products. Manufacturing concentration creates real…
Key Takeaways The U.S. pet supplement review ecosystem runs almost entirely on affiliate commissions, meaning a site’s “top pick” is often its highest-paying advertiser, not its highest-rated product. FTC endorsement guides (16 CFR 255) require clear disclosure whenever a reviewer receives compensation tied to a sale, yet a census of 25 pet supplement ranking pages…
Do Postbiotic Dog Supplements Actually Work? Separating Hype from Evidence | Dog Supplement Report Home » Mythbusting » Postbiotic Dog Supplements Investigation By Marisol Reyes, Investigative Editor — Dog Supplement Report · Reviewed by Dr. Kira Wendel, DVM Key Takeaways “Postbiotic” is a defined scientific category — not a marketing synonym for probiotic, and not…
“`html Do ‘Calming’ Dog Supplements Actually Work? Separating Evidence from Marketing By Dr. Marcus R. Holloway, DVM | Published August 2026 | Reading time: 12 minutes Dogs experience anxiety. Thunderstorms, fireworks, separation, car rides, vet visits — the triggers are real, and so is the distress. A genuine behavioral or medical problem deserves evidence-based support,…
“`html By the Editorial Team — Dog Supplement Report | Published: 2026 | Reviewed for accuracy against FDA 21 CFR 507, AAFCO guidelines, and peer-reviewed veterinary literature. A walk down any boutique pet store aisle reveals supplement bottles stamped with phrases like “Made in a Human-Grade Facility,” “Kitchen-Quality Ingredients,” and “If It’s Not Good Enough…
By the Editorial Team, Dog Supplement Report Key Takeaways The “30 Billion CFU” headline number on most soft-chew labels reflects colony-forming units at the time of manufacture — not at the point of sale, and almost never at the expiration date on the bottle. Peer-reviewed literature documents that probiotic viability in soft-chew formats drops significantly…
Key Takeaways The gut-skin axis in dogs is a real, peer-reviewed phenomenon — but the published evidence supports adjunctive benefit for atopic dermatitis, not a cure for allergies. Three mechanisms have randomized controlled trial backing in dogs: omega-3 fatty acid supplementation, certain postbiotic preparations, and selected prebiotic fibers. “Probiotic fixes allergies” claims rely on extrapolation…
Key Takeaways Strain count is a marketing number, not a clinical outcome. The human and canine literature does not show that 15 or 20 strains outperform a well-chosen 2- or 3-strain formula. The “more is better” framing exploits a consumer heuristic borrowed from CFU counts and applies it where it has no validated meaning. Strain-stacking…